Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Tropical diseases pipeline

Tropical diseases pipeline

Company Product Indication Status
Novartis (NYSE:NVS; SWX:NOVN) Coartem artemether (A)/lumefantrine Malaria Approved ex-U.S.; under review in U.S.

Read the full 279 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE